Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-04

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Real-time Continuous Glucose Monitoring on Glucose Control and Outcomes of Critically Ill Patients

NCT01992965

Hyperglycemia

UNKNOWN NA

Assessment of the Accuracy,Feasibility,Safety of Continuous Glucose Monitoring System

NCT03120091

Continuous Glucose Monitoring System Accuracy Feasibility +1 more

COMPLETED

Continuous Glucose Monitoring in Intensive Care Unit

NCT05585801

Blood Glucose Critical Care

RECRUITING NA

The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients

NCT07201155

Hyperglycemia in Critically Ill Patients

COMPLETED

Exploration of Continuous Glucose Monitoring on the Intensive Care Unit

NCT06645873

Hypoglycemia, Hyperglycemia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critically Ill Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous Glucose Monitoring (CGM) System

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥ 18 years; gender not limited.
2. Expected ICU (Intensive Care Unit) stay ≥ 48 hours.
3. Patients requiring frequent blood gas monitoring in the ICU.

Exclusion Criteria

1. The patient or their family refuses to use CGM for blood glucose monitoring.
2. Patients with adverse skin conditions (such as rash, active inflammation, etc.) in the device placement area, or those requiring emergency surgical intervention in that area.
3. Patients who need to undergo computed tomography (CT), X-ray, or magnetic resonance imaging (MRI) scans on the device placement area during the study period.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No